Rain Therapeutics

-$0.44 (-2.38%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RAIN and other stocks, options, and ETFs commission-free!

About RAIN

Rain Therapeutics Inc. Common Stock, also called Rain Therapeutics, is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer.

CEO
Avanish Vellanki
Employees
—
Headquarters
Newark, California
Founded
2017

RAIN Key Statistics

Market Cap
499.99M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
144.69K
High Today
$19.21
Low Today
$17.96
Open Price
$18.02
Volume
353.36K
52 Week High
$23.90
52 Week Low
$14.08

RAIN Earnings

-$1.93
-$1.29
-$0.64
$0.00
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 16, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure